Success Story: Direct Premium Processing NIW Approval in Just 28 Days for a Researcher From Egypt
Client’s Testimonial:
"Thank you for your work on my case. I truly appreciate the professionalism during my case."
On April 15th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Internal Medicine Resident Physician in the Field of Endocrinology Medicine (Approval Notice).
General Field: Endocrinology Medicine
Position at the Time of Case Filing: Internal Medicine Resident Physician
Country of Origin: Egypt
State of Residence at the Time of Filing: New York
Approval Notice Date: April 15th, 2026
Processing Time: 28 days (Premium Processing Requested)
Case Summary:
The client, who received an MBBCh, works in the field of endocrinology medicine. In the petition, we presented the client’s proposed endeavor as continuing research that integrates multicenter clinical studies, molecular analyses, machine learning approaches, and literature reviews to investigate endocrine disorders and cardiometabolic risk factors, particularly primary aldosteronism, mild autonomous cortisol secretion, Cushing Syndrome, and related hypertension and obesity. We explained that this work was nationally important because it aimed to improve early recognition, risk stratification, and management strategies for patients with complex endocrine and metabolic conditions.
The client’s publication record also supported the case well. He had authored 7 peer-reviewed journal articles, 12 conference abstracts, including 3 first-authored abstracts, and 1 preprint with a total of 18 citations. We did not present those numbers as automatically persuasive. Instead, we showed what they meant in context. This body of work reflected sustained activity across clinically relevant endocrine and cardiometabolic topics and helped establish that the client was already contributing to the evidence base in this field.
The petition also included 1 recommendation letter from an expert familiar with the client’s work. That letter reinforced the quality of the client’s research, explained why his publications mattered, and supported the conclusion that he was well-positioned to continue advancing this endeavor.
This case was approved as an I-140 NIW through Direct Premium Processing in just 28 days. We were delighted to help the client secure this result and look forward to his continued contributions to endocrinology medicine and improved care for patients with complex endocrine and metabolic disorders.